Tidal Wave of Litigation: Multiple lawsuits filed against Novo Nordisk and Eli Lilly have alleged that manufacturers failed to adequately warn patients and healthcare providers about the potential risk of non-arteritic anterior ischemic optic neuropathy (NAION) and other vision-related complications associated with their products
Methods To determine insurance market enrollment, the National Health Interview Survey (NHIS) hierarchy for primary coverage among people under age 65 was used
One such treatment gaining popularity is Ozempic, a GLP-1 receptor agonist designed to aid in both diabetes management and weight loss
To receive Washington Poison Center news in your inbox, sign up here
What you do get with Peak though is clinical oversight: before each refill, a medical professional reviews a short check-in on how your side effects and results are going, and can hold or adjust your dose instead of automatically moving you up
In the first six months, many people aim to lose about 10% of their body weight